| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/16/2005 | WO2005014029A3 Use of dg008, dg065, dg210 or dg 239 secreted protein products for preventing and treating pancreatic diseases, obesity or metabolic syndrome |
| 06/16/2005 | WO2005013899A9 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/16/2005 | WO2005005598A3 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 06/16/2005 | WO2005004800A3 Trypanosome derived apoptotic factors (taf) |
| 06/16/2005 | WO2005003154A8 Compositions and methods for the diagnosis and treatment of tumor |
| 06/16/2005 | WO2005001048A3 Preparation and application of anti-tumor bifunctional fusion proteins |
| 06/16/2005 | WO2005000359A3 Chemically-modified human growth hormone conjugates |
| 06/16/2005 | WO2005000235A3 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME |
| 06/16/2005 | WO2004113539A3 Method for producing a recombinant protein of interest and protein thus produced |
| 06/16/2005 | WO2004108900A3 Plant transcriptional regulators of disease resistance |
| 06/16/2005 | WO2004106936A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 9 (p2y9) |
| 06/16/2005 | WO2004106367A3 Enterococcus antigens |
| 06/16/2005 | WO2004099782A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 06/16/2005 | WO2004099242A3 Streptococcus agalactiae antigens i + ii |
| 06/16/2005 | WO2004098536A3 Anti-viral activity of cathelicidin peptides |
| 06/16/2005 | WO2004096272A3 Methods and compositions for modulating the interaction between adiponectin and its receptor |
| 06/16/2005 | WO2004094471A3 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 06/16/2005 | WO2004083445A3 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof |
| 06/16/2005 | WO2004081199A3 Novel compositions and methods for the treatment of immune related disease |
| 06/16/2005 | WO2004064501A3 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins |
| 06/16/2005 | WO2004060280A3 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 06/16/2005 | WO2004058166A3 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | WO2004047855A3 Proteins involved in the regulation of energy homeostasis |
| 06/16/2005 | WO2004043238A8 Biomarkers for intra-amniotic inflammation |
| 06/16/2005 | WO2004037195A3 Treatment of diabetes |
| 06/16/2005 | WO2004035006A3 Methods and compositions for immunization against hiv |
| 06/16/2005 | WO2004033642A3 Alpha 2hs glycoprotein for treatment of cancer and a method for preparation thereof |
| 06/16/2005 | WO2004031360A3 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 06/16/2005 | WO2003093423A3 Mta1s, a steroid hormone receptor corepressor |
| 06/16/2005 | WO2003091390A3 Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher |
| 06/16/2005 | WO2003074656A3 Rank-ligand-induced sodium/proton antiporter polypeptides |
| 06/16/2005 | WO2003033646A3 Compositions and methods for the modulation of viral maturation |
| 06/16/2005 | WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 06/16/2005 | WO2003006621A3 Super osteocalcin promoter for the treatment of calcified tumors and tissues |
| 06/16/2005 | WO2000053621A3 Synthetic complementary peptides and ophthalmologic uses thereof |
| 06/16/2005 | US20050132446 Nucleic acid obtainable from the VRN2 locus of a plant, which nucleic acid encodes a polypeptide which is capable of affecting vernalization response, flowering time, leaf size, and/or shape or shade avoidance response |
| 06/16/2005 | US20050132445 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 06/16/2005 | US20050132443 Ethylene-responsive transcription coactivators in plant |
| 06/16/2005 | US20050132439 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
| 06/16/2005 | US20050132438 Expression vector comprising nucleotide sequence coding modulator which induces systemic aquired resistance in plants for use in generation and propagation of disease resistant plants |
| 06/16/2005 | US20050132434 transgenic plant exhibits tolerance to normally toxic levels of glyphosate; DNA is of EPSP synthase operably linked to an actin promoter; into the genome of said plant or a plant of a previous generation thereof by microprojectile bombardment |
| 06/16/2005 | US20050132429 Non-human mutant mammals deficient in Sigma receptors and their applications |
| 06/16/2005 | US20050132427 Monitoring cell proliferation in rodent animal model after inoculation with tumor cell line; cancer propagation and antiproliferative agents |
| 06/16/2005 | US20050131648 Screening assays for agonists or antagonists of CD40 signaling |
| 06/16/2005 | US20050131222 Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| 06/16/2005 | US20050131221 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 06/16/2005 | US20050131219 Methods for reducing complexity of a sample using small epitope antibodies |
| 06/16/2005 | US20050131218 Used to study cellular processes such as immune regulation, cell proliferation, cell death, and inflammatory responses |
| 06/16/2005 | US20050131215 Nucleotide sequences coding ribosomal polypeptides for use as tool in detection of modulator for treatment of bacterial infection; bactericides; microbiocides |
| 06/16/2005 | US20050131214 Cytokine polypeptide for use as tool in tissue repair |
| 06/16/2005 | US20050131213 Isolating interferon polypeptides using size exclusion chromatography; antitumor agents; viricides; immunomodulators |
| 06/16/2005 | US20050131212 Neurogenic peptide for use in enhancement of neuronal migration, proliferation, survival, differentiation, and/or neurite outgrowth |
| 06/16/2005 | US20050131211 Designed protein pores as components for biosensors |
| 06/16/2005 | US20050131210 Genes and proteins, and their use |
| 06/16/2005 | US20050131209 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same |
| 06/16/2005 | US20050131208 Method for producing a modified peptide |
| 06/16/2005 | US20050130928 Modulating mammalian midkine activity; alters pulmonary vasculature development and smooth muscle cell development |
| 06/16/2005 | US20050130926 Drug screening; cancer diagnosis; host cells |
| 06/16/2005 | US20050130921 Vibrionaceae replication factors and methods of use thereof |
| 06/16/2005 | US20050130920 Promotes a prolonged, directed cytotoxic T cell response to the target cell; cancer; vaccine |
| 06/16/2005 | US20050130919 Allow for inhibition of the expression of target alleles in a spatially and temporally regulatable manner; useful for investigating gene functions; genetic engineering |
| 06/16/2005 | US20050130917 Preventing the attachment of Neisserial cells to epithelial cells (nasopharynx tract); antibodies, mutant proteins and nucleic acid from the adhesion-specific genes |
| 06/16/2005 | US20050130916 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130895 Radiolabelled shiga-like toxins as ANTITUMOR AGENTS for treating ovarian, breast, and brain tumors; imaging a tumor in a mammal |
| 06/16/2005 | US20050130892 B-cell activation factor for use in diagnosis, prevention and treatment of glomerulonephritis and autoimmune diseases |
| 06/16/2005 | US20050130891 Containing at least two of the following active substances A, B, C, wherein: A=at least one hormone stimulating the production of cAMP; B=at least one substance inhibiting the degradation of a cyclic nucleotide; C=at least one hormone stimulating the production of cGMP |
| 06/16/2005 | US20050130890 For N-formylpeptide receptor class receptors, which mediate the inflammation associated with Alzheimer's disease. |
| 06/16/2005 | US20050130889 Analog further comprises an amino acid substitution wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid; for treating gram-negative bacterial infections in a subject; bactericidal for gram-positive bacteria and mycoplasma; enhances effectiveness of antibiotics |
| 06/16/2005 | US20050130887 Method of diagnosis and detection of potential carriers of mutated gene, bone related diseases; gene therapy recombinant technology and therapy using information derived from the DNA, protein and the function of the protein |
| 06/16/2005 | US20050130885 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130884 Pharmacologically active antiviral peptides and methods of their use |
| 06/16/2005 | US20050130857 Extracting sericin protein from Thai silk by heating the water mixture of silk fiber or cocoons; soften the skin; no irritation; antiallergens |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130302 Method and composition for regulating expansion of stem cells |
| 06/16/2005 | US20050130298 Human Embryonic Kidney (HEK293); generates appropriate level of membrane voltage, responds to potassium chloride sensitively; only T-type calcium channel activated; investigation different from traditional electrophysiological method |
| 06/16/2005 | US20050130287 Purifying process of soluble proteins of the l.obliqua bristles through prothrombin activation: process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction II, n-terminal and internal fragments sequences |
| 06/16/2005 | US20050130271 Method of suppressing differentiation by administering a human serrate-1 polypeptide |
| 06/16/2005 | US20050130269 Membrane protein fusion for use as diagnostic tool in genetic engineering; reporter gene expression |
| 06/16/2005 | US20050130268 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs; host cell |
| 06/16/2005 | US20050130267 Modulation of gene expression using localization domains |
| 06/16/2005 | US20050130265 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/16/2005 | US20050130264 Nucleotide sequences which code for the rpoB gene |
| 06/16/2005 | US20050130262 Mutated photoproteins and their uses |
| 06/16/2005 | US20050130261 Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms |
| 06/16/2005 | US20050130260 Refolded membrane protein in monodisperse form |
| 06/16/2005 | US20050130258 Nucleotide sequences coding heat shock protein which self-assembles into regular double-ring structures for use as component of multi-dimensional addressable arrays |
| 06/16/2005 | US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits |
| 06/16/2005 | US20050130227 Expression vector comprising nucleotide sequences coding G+C-rich promoter binding protein (mGPBP) for use in diagnosis, prvrntion and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 06/16/2005 | US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130206 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 06/16/2005 | US20050130204 Protein-transport-associated molecules |
| 06/16/2005 | US20050130203 Novel GABAB receptor DNA sequences |
| 06/16/2005 | US20050130190 Mutations in ion channel proteins associated with sudden cardiac death |
| 06/16/2005 | US20050130182 Comparing: abundance of one or more marker polypeptides selected from the group consisting of: fibrinogen alpha -chain, fibrinogen beta -chain, fibrinopeptide A, in a patient sample, the normal abundance of the one or more of marker polypeptides in a sample from a control not afflicted with endometriosis |
| 06/16/2005 | US20050130175 Expression vector comprising nucleotide sequences coding mitotic regulatory protein (TOME-1) for use as too in detection prevention and treatment of cell proliferative disorders |
| 06/16/2005 | US20050130151 Fragile X mental retardation protein (FMRP) binding site for use as tool in detection, treatment and prevention of cognitive and motor disorders |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130143 Human smooth muscle myosin heavy chain polypeptide (hSMMyHC 7polypeptide) for use as tool in identifying modulator for prevention and treatment of hypertension, hypotension, heart and respiratory disorders |